Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome

HU Lifen; GONG Lei; LI Chunhui; YIN Jun; YE Ying; GAO Yufeng; YANG Fan; LI Jun; QU Tingting; CHENG Jun; YIN Huafa; XU Xihai; WU Ting; CUI Ning; WANG Gang; HUANG Xiaoping; XU Feng; XU Jing; YANG Jianghua; RAO Jianguo; ZHU Liyu; LIU Zhenjun; WU Jiabing; LIU Wei; LI Jiabin

doi:10.16462/j.cnki.zhjbkz.2024.06.001

Volume 28 Issue 6

Jun. 2024

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2024 > 28(6): 621-628

HU Lifen, GONG Lei, LI Chunhui, YIN Jun, YE Ying, GAO Yufeng, YANG Fan, LI Jun, QU Tingting, CHENG Jun, YIN Huafa, XU Xihai, WU Ting, CUI Ning, WANG Gang, HUANG Xiaoping, XU Feng, XU Jing, YANG Jianghua, RAO Jianguo, ZHU Liyu, LIU Zhenjun, WU Jiabing, LIU Wei, LI Jiabin. Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001

Citation:

HU Lifen, GONG Lei, LI Chunhui, YIN Jun, YE Ying, GAO Yufeng, YANG Fan, LI Jun, QU Tingting, CHENG Jun, YIN Huafa, XU Xihai, WU Ting, CUI Ning, WANG Gang, HUANG Xiaoping, XU Feng, XU Jing, YANG Jianghua, RAO Jianguo, ZHU Liyu, LIU Zhenjun, WU Jiabing, LIU Wei, LI Jiabin. Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001

Citation:

HU Lifen, GONG Lei, LI Chunhui, YIN Jun, YE Ying, GAO Yufeng, YANG Fan, LI Jun, QU Tingting, CHENG Jun, YIN Huafa, XU Xihai, WU Ting, CUI Ning, WANG Gang, HUANG Xiaoping, XU Feng, XU Jing, YANG Jianghua, RAO Jianguo, ZHU Liyu, LIU Zhenjun, WU Jiabing, LIU Wei, LI Jiabin. Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001

PDF( 1064 KB)

Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome

doi: 10.16462/j.cnki.zhjbkz.2024.06.001

HU Lifen^{1, 2},
GONG Lei³,
LI Chunhui⁴,
YIN Jun⁵,
YE Ying^{1, 2},
GAO Yufeng^{1, 2},
YANG Fan⁶,
LI Jun⁷,
QU Tingting⁸,
CHENG Jun^{1, 2},
YIN Huafa⁹,
XU Xihai^{1, 2},
WU Ting^{1, 2},
CUI Ning¹⁰,
WANG Gang¹¹,
HUANG Xiaoping¹²,
XU Feng¹³,
XU Jing¹⁴,
YANG Jianghua¹⁵,
RAO Jianguo¹⁶,
ZHU Liyu¹⁷,
LIU Zhenjun¹⁸,
WU Jiabing^{3
,
,},
LIU Wei^{19
,
,},
LI Jiabin^{1, 2
,
,}

1.
Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
2.
Anhui Province Key Laboratory of Infectious Diseases, Hefei 230022, China
3.
Anhui Center for Disease Control and Prevention, Hefei 230022, China
4.
Infection Control Center, Xiangya Hospital of Central South University, Changsha 410008, China
5.
Hospital Infection-Control Department, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
6.
Hospital Infection-Control Department, Huashan Hospital, Fudan University, Shanghai 200040, China
7.
Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210006, China
8.
Hospital Infection-Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
9.
Department of Infectious Diseases, Public Health Clinical Center of Anhui Province, Hefei 230022, China
10.
Department of Infectious Diseases, The 154^th Hospital, Xinyang 464000, China
11.
Department of Infectious Diseases, Qilu Hospital, Shandong University, Jinan 250012, China
12.
Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou 215006, China
13.
Department of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
14.
Department of Infectious Diseases, The First Affiliated Hospital of University of Science and Technology of China, Hefei 230036, China
15.
Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, China
16.
Department of Infectious Diseases, Lu′an People′s Hospital of Anhui Province, Lu′an 237000, China
17.
Department of Infectious Diseases, Chaohu Hospital of Anhui Medical University, Chaohu 238001, China
18.
Department of Infectious Diseases, Anqing Municipal Hospital, Anqing 246003, China
19.
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing 100850, China

Funds:

The National Natural Science Foundation of China 82330103

The National Natural Science Foundation of China 82370016

The Key Research and Development Plan Project of Anhui Province 2022e07020043

The Key Health Research Projects of Anhui Province AHWJ2022a018

Anhui Province University Natural Science Team Project 2023AH010083

More Information

Corresponding author: WU Jiabing, E-mail: wjb0386@126.com; LIU Wei, E-mail: lwbime@163.com; LI Jiabin, E-mail: lijiabin@ahmu.edu.cn
Received Date: 2024-03-20
Rev Recd Date: 2024-05-13

Available Online: 2024-07-13

Publish Date: 2024-06-10

Abstract

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by Dabie bandavirus (DBV) transmitted through tick bites. It was initially identified in 2009 among febrile patients with leukopenia and thrombocytopenia in central China. SFTS has been recently reported in other Asia countries, resulting in high mortality among severely ill patients. In the recent 10 years, there have been some reports about human-to-human transmission of DBV, particularly among severely ill patients. However, there are currently no established prevention and control measures for medical staff during the clinical treatment for severely ill SFTS patients against human-to-human transmission. Improper precaution measure can cause nosocomial infection of DBV among medical staff during the clinical process of rescue and treatment. Therefore, it is crucial to develop preventive and control measures against DBV′s human-to-human transmission, which would significantly contribute to the management of severely ill SFTS patients. To better regulate the precaution measures strategies against DBV human-to-human transmission, we have invited renowned experts in this field for extensive discussions, and reached a consensus on prevention and control measures concerning SFTS epidemiological features, contact transmission through patient′s blood and bloody secretions, aerosol transmission, as well as patient′s contaminants handling and corpse disposal.
- Severe fever with thrombocytopenia syndrome,
- Dabie bandavirus,
- Human-to-human communication,
- Precaution measures

FullText(HTML)

References(52)

References

[1]	Guo CT, Lu QB, Ding SJ, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis[J]. Epidemiol Infect, 2016, 144(6): 1345-1354. DOI: 10.1017/S0950268815002678.
[2]	Liu W, Lu QB, Cui N, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome[J]. Clin Infect Dis, 2013, 57(9): 1292-1299. DOI: 10.1093/cid/cit530.
[3]	Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012[J]. Emerg Infect Dis, 2013, 19(11): 1892-1894. DOI: 10.3201/eid1911.130792.
[4]	Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan[J]. J Infect Dis, 2014, 209(6): 816-827. DOI: 10.1093/infdis/jit603.
[5]	Kobayashi Y, Kato H, Yamagishi T, et al. Severe fever with thrombocytopenia syndrome, Japan, 2013-2017[J]. Emerg Infect Dis, 2020, 26(4): 692-699. DOI: 10.3201/eid2604.191011.
[6]	Li JC, Zhao J, Li H, et al. Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome[J]. Infect Med, 2022, 1(1): 40-49. DOI: 10.1016/j.imj.2021.10.001.
[7]	Mehand MS, Millett P, Al-Shorbaji F, et al. World health organization methodology to prioritize emerging infectious diseases in need of research and development[J]. Emerg Infect Dis, 2018, 24(9): e171427. DOI: 10.3201/eid2409.171427.
[8]	Bao CJ, Guo XL, Qi X, et al. A family cluster of infections by a newly recognized bunyavirus in Eastern China, 2007: further evidence of person-to-person transmission[J]. Clin Infect Dis, 2011, 53(12): 1208-1214. DOI: 10.1093/cid/cir732.
[9]	Gai ZT, Liang MF, Zhang Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact[J]. Clin Infect Dis, 2012, 54(2): 249-252. DOI: 10.1093/cid/cir776.
[10]	Liu Y, Li Q, Hu WF, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus[J]. Vector Borne Zoonotic Dis, 2012, 12(2): 156-160. DOI: 10.1089/vbz.2011.0758.
[11]	Tang XY, Wu WL, Wang HF, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood[J]. J Infect Dis, 2013, 207(5): 736-739. DOI: 10.1093/infdis/jis748.
[12]	Chen HB, Hu K, Zou JJ, et al. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus[J]. Int J Infect Dis, 2013, 17(3): e206-e208. DOI: 10.1016/j.ijid.2012.11.006.
[13]	Wang YL, Deng BC, Zhang J, et al. Person-to-person asymptomatic infection of severe fever with thrombocytopenia syndrome virus through blood contact[J]. Intern Med, 2014, 53(8): 903-906. DOI: 10.2169/internalmedicine.53.1164.
[14]	Jiang XL, Zhang S, Jiang M, et al. A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China[J]. Clin Microbiol Infect, 2015, 21(3): 274-279. DOI: 10.1016/j.cmi.2014.10.006.
[15]	Gong Z, Gu S, Zhang Y, et al. Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China[J]. Clin Microbiol Infect, 2015, 21(12): 1115-1120. DOI: 10.1016/j.cmi.2015.07.024.
[16]	Kim WY, Choi W, Park SW, et al. Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea[J]. Clin Infect Dis, 2015, 60(11): 1681-1683. DOI: 10.1093/cid/civ128.
[17]	Yoo JR, Heo ST, Park D, et al. Family cluster analysis of severe fever with thrombocytopenia syndrome virus infection in Korea[J]. Am J Trop Med Hyg, 2016, 95(6): 1351-1357. DOI: 10.4269/ajtmh.16-0527.
[18]	Huang DY, Jiang YP, Liu XP, et al. A cluster of symptomatic and asymptomatic infections of severe fever with thrombocytopenia syndrome caused by person-to-person transmission[J]. Am J Trop Med Hyg, 2017, 97(2): 396-402. DOI: 10.4269/ajtmh.17-0059.
[19]	Gong L, Song DD, Wu JB, et al. Human-to-human transmissions of severe fever with thrombocytopenia syndrome virus in Anhui Province, 2010-2017[J]. Clin Microbiol Infect, 2018, 24(8): 920-922. DOI: 10.1016/j.cmi.2018.03.014.
[20]	Moon J, Lee H, Jeon JH, et al. Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation[J]. Infect Control Hosp Epidemiol, 2019, 40(2): 238-241. DOI: 10.1017/ice.2018.330.
[21]	Jung IY, Choi W, Kim J, et al. Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome[J]. Clin Microbiol Infect, 2019, 25(5): 633.e1-633633.e4. DOI: 10.1016/j.cmi.2019.01.006.
[22]	Tao MY, Liu Y, Ling F, et al. Characteristics of three person-to-person transmission clusters of severe fever with thrombocytopenia syndrome in southeastern China[J]. Am J Trop Med Hyg, 2021, 105(3): 794-800. DOI: 10.4269/ajtmh.21-0366.
[23]	Ye C, Qi R. Risk factors for person-to-person transmission of severe fever with thrombocytopenia syndrome[J]. Infect Control Hosp Epidemiol, 2021, 42(5): 582-585. DOI: 10.1017/ice.2020.1258.
[24]	Fang XY, Hu JL, Peng ZH, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome bunyavirus human-to-human transmission[J]. PLoS Negl Trop Dis, 2021, 15(4): e0009037. DOI: 10.1371/journal.pntd.0009037.
[25]	Wu YX, Yang X, Leng Y, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome virus through potential ocular exposure to infectious blood[J]. Int J Infect Dis, 2022, 123: 80-83. DOI: 10.1016/j.ijid.2022.08.008.
[26]	Hu L, Li J, Zhang H, et al. Predisposing factors for person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus[J]. J Hosp Infect, 2022, 123: 174-178. DOI: 10.1016/j.jhin.2021.10.023.
[27]	Bae S, Chang HH, Kim SW, et al. Nosocomial outbreak of severe fever with thrombocytopenia syndrome among healthcare workers in a single hospital in Daegu, Korea[J]. Int J Infect Dis, 2022, 119: 95-101. DOI: 10.1016/j.ijid.2022.03.048.
[28]	杨鑫, 武永祥, 冷昱, 等. 两起发热伴血小板减少综合征聚集性疫情流行病学及病原学分析[J]. 遗传, 2023, 45(11): 1062-1073. DOI: 10.16288/j.yczz.23-176. Yang X, Wu YX, Leng Y, et al. Epidemiololgical and etiological analysis of two clusters of severe fever with thrombocytopenia syndrome[J]. Hereditas, 2023, 45(11): 1062-1073. DOI: 10.16288/j.yczz.23-176.
[29]	张爱平, 梁曼曼, 王子健, 等. 对比分析蜱传人和人传人致发热伴血小板减少综合征的临床特征及预后[J]. 新发传染病电子杂志, 2022, 7(1): 26-29. DOI: 10.19871/j.cnki.xfcrbzz.2022.01.006. Zhang AP, Liang MM, Wang ZJ, et al. Comparison of clinical features and prognosis of severe fever with thrombocytopenia syndrome transmitted from tick-to-person versus person-to-person[J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 26-29. DOI: 10.19871/j.cnki.xfcrbzz.2022.01.006.
[30]	李懿, 王笑阳, 李亚飞, 等. 2022年河南省两起发热伴血小板减少综合征聚集性疫情流行病学及病原学调查[J]. 中华预防医学杂志, 2023, 57(10): 1719-1724. DOI: 10.3760/cma.j.cn112150-20221130-01162. Li Y, Wang XY, Li YF, et al. The epidemiology and pathogeny investigation of two clusters of severe fever with thrombocytopenia syndrome disease outbreaking in Henan Province, 2022[J]. Chin J Prev Med, 2023, 57(10): 1719-1724. DOI: 10.3760/cma.j.cn112150-20221130-01162.
[31]	张全福, 李建东, 姜晓林, 等. 发热伴血小板减少综合征病毒热稳定性和灭活条件初步研究[J]. 中华实验和临床病毒学杂志, 2014, 28(3): 206-208. DOI: 10.3760/cma.j.issn.1003-9279.2014.03.016. Zhang QF, Li JD, Jiang XL, et al. A primary study of the thermal stability and inactivation of severe fever with thrombocytopenia syndrome virus[J]. Chin J Exp Clin Virol, 2014, 28(3): 206-208. DOI: 10.3760/cma.j.issn.1003-9279.2014.03.016.
[32]	杨晓艺, 杜珊珊, 黄晓霞, 等. 发热伴血小板减少综合征病毒在不同环境条件下的稳定性研究[J]. 病毒学报, 2023, 39(6): 1521-1527. DOI: 10.13242/j.cnki.bingduxuebao.004391. Yang XY, Du SS, Huang XX, et al. Comparative study on the environmental stability of severe fever with thrombocytopenia syndrome virus[J]. Chinese Journal of Virology, 2023, 39(6): 1521-1527. DOI: 10.13242/j.cnki.bingduxuebao.004391.
[33]	陈秋兰, 朱曼桐, 陈宁, 等. 2011-2021年全国发热伴血小板减少综合征流行特征分析[J]. 中华流行病学杂志, 2022, 43(6): 852-859. DOI: 10.3760/cma.j.cn112338-20220325-00228. Chen QL, Zhu MT, Chen N, et al. Epidemiological characteristics of severe fever with thtrombocytopenia syndrome in China, 2011-2021[J]. Chin J Epidemiol, 2022, 43(6): 852-859. DOI: 10.3760/cma.j.cn112338-20220325-00228.
[34]	Tran XC, Yun Y, An L, et al. Endemic severe fever with thrombocytopenia syndrome, Vietnam[J]. Emerg Infect Dis, 2019, 25(5): 1029-1031. DOI: 10.3201/eid2505.181463.
[35]	Win AM, Nguyen YTH, Kim Y, et al. Genotypic heterogeneity of Orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome co-infection, Myanmar[J]. Emerg Infect Dis, 2020, 26(8): 1878-1881. DOI: 10.3201/eid2608.200135.
[36]	Zohaib A, Zhang JY, Saqib M, et al. Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan[J]. Emerg Infect Dis, 2020, 26(7): 1513-1516. DOI: 10.3201/eid2607.190611.
[37]	Lin TL, Ou SC, Maeda K, et al. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan[J]. Emerg Microbes Infect, 2020, 9(1): 148-151. DOI: 10.1080/22221751.2019.1710436.
[38]	Casel MA, Park SJ, Choi YK. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy[J]. Exp Mol Med, 2021, 53(5): 713-722. DOI: 10.1038/s12276-021-00610-1.
[39]	Zhao L, Li J, Cui XM, et al. Distribution of Haemaphysalis longicornis and associated pathogens: analysis of pooled data from a China field survey and global published data[J]. Lancet Planet Health, 2020, 4(8): e320-e329. DOI: 10.1016/S2542-5196(20)30145-5.
[40]	Zhang X, Zhao CY, Cheng CY, et al. Rapid spread of severe fever with thrombocytopenia syndrome virus by parthenogenetic Asian longhorned ticks[J]. Emerg Infect Dis, 2022, 28(2): 363-372. DOI: 10.3201/eid2802.211532.
[41]	Wang JN, Li TQ, Liu QM, et al. Vectors, hosts, and the possible risk factors associated with severe fever with thrombocytopenia syndrome[J]. J Can Des Mal Infect De La Microbiol Med, 2021, 2021: 8518189. DOI: 10.1155/2021/8518189.
[42]	Park ES, Shimojima M, Nagata N, et al. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats[J]. Sci Rep, 2019, 9(1): 11990. DOI: 10.1038/s41598-019-48317-8.
[43]	Yamanaka A, Kirino Y, Fujimoto S, et al. Direct transmission of severe fever with thrombocytopenia syndrome virus from domestic cat to veterinary personnel[J]. Emerg Infect Dis, 2020, 26(12): 2994-2998. DOI: 10.3201/eid2612.191513.
[44]	Kida K, Matsuoka Y, Shimoda T, et al. A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus[J]. Jpn J Infect Dis, 2019, 72(5): 356-358. DOI: 10.7883/yoken.JJID.2018.526.
[45]	Tsuru M, Suzuki T, Murakami T, et al. Pathological characteristics of a patient with severe fever with thrombocytopenia syndrome (SFTS) infected with SFTS virus through a sick cat's bite[J]. Viruses, 2021, 13(2): 204. DOI: 10.3390/v13020204.
[46]	Mekata H, Kawaguchi T, Iwao K, et al. Possible transmission of severe fever with the thrombocytopenia syndrome virus to an individual who buried an infected cat[J]. Jpn J Infect Dis, 2023, 76(3): 211-214. DOI: 10.7883/yoken.JJID.2022.425.
[47]	Kaneko C, Mekata H, Umeki K, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in medium-sized wild mammals in Miyazaki, Japan[J]. Ticks Tick Borne Dis, 2023, 14(2): 102115. DOI: 10.1016/j.ttbdis.2022.102115.
[48]	李兵, 刘元东, 周光智, 等. 发热伴血小板减少综合征的流行病学特征及防治措施[J]. 解放军预防医学杂志, 2017, 35(12): 1623-1626. DOI: 10.13704/j.cnki.jyyx.2017.12.043. Li B, Liu YD, Zhou GZ, et al. Epidemiological characteristics and preventive measures of fever with thrombocytopenia syndrome[J]. J Prev Med Chin Peopl Liber Army, 2017, 35(12): 1623-1626. DOI: 10.13704/j.cnki.jyyx.2017.12.043.
[49]	Dualis H, Zefong AC, Joo LK, et al. Factors and outcomes in severe fever with thrombocytopenia syndrome (SFTS): a systematic review[J]. Ann Med Surg, 2021, 67: 102501. DOI: 10.1016/j.amsu.2021.102501.
[50]	Li H, Lu QB, Xing B, et al. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study[J]. Lancet Infect Dis, 2018, 18(10): 1127-1137. DOI: 10.1016/S1473-3099(18)30293-7.
[51]	Ryu BH, Kim JY, Kim T, et al. Extensive severe fever with thrombocytopenia syndrome virus contamination in surrounding environment in patient rooms[J]. Clin Microbiol Infect, 2018, 24(8): 911.e1-911911.e4. DOI: 10.1016/j.cmi.2018.01.005.
[52]	Wei XM, Li SH, Lu Y, et al. Severe fever with thrombocytopenia syndrome virus aerosol infection in C57/BL6 mice[J]. Virology, 2023, 581: 58-62. DOI: 10.1016/j.virol.2023.03.001.